Public Research Library
Specialties:
Most Popular Reports:
- Laser Body Sculpting SmartLipo-Trends in Use
- Essure Permanent Birth Control
- Oral Contraceptives Market Evaluation
- Trends and Forecast of Dental Implant Cases
- Avastin and the AVADO Trial Survey
Newest Reports:
Avastin: Trends IN USE in Breast Cancer
A Survey of 108 Oncologists
Study Description
|
Topic |
Avastin for metastatic breast cancer treatment |
|
Respondent Type |
Physicians |
|
Specialties Covered |
Oncology |
|
Region |
United States Only |
|
Methodology |
Online survey, self-administered via a Panel Intelligence website § 30-40 minutes duration § 108 total respondents § Fielded online from October 9-10, 2007 |
Objectives
To understand current practices and trends in the treatment of metastatic breast cancer with Avastin by conducting a survey of oncologists.
§ Quantify usage of current treatment regimens at various stages of treatment
§ Explore specific drug combinations
§ Understand variations among stages
§ Understand key barriers and drivers of Avastin use in metastatic breast cancer
Companies and Products Mentioned in This Report
|
Company |
Ticker Symbol |
Product(s) |
|
Genentech |
DNA |
Avastin & Herceptin |
Inclusion Criteria and Respondent Demographics
|
Inclusion Criteria
|
§ US-based, board certified medical oncologists or hematologist/oncologists § Have treated at least 10 metastatic breast cancer patients in the past 3 months § 2 to 30 years of practice experience § Spend 50%+ of professional time in clinical practice |
Reports become free one year after the publication date.
 about us contact us |
 |
| © Panel Intelligence, LLC. 1999-2008. All rights reserved. A wholly owned subsidiary of MCF Corporation (NASDAQ: MERR) Privacy Policy |